tiprankstipranks
Trending News
More News >
GeneTether Therapeutics, Inc. (TSE:RIZE)
:RIZE
Canadian Market
Advertisement

GeneTether Therapeutics, Inc. (RIZE) Price & Analysis

Compare
3 Followers

RIZE Stock Chart & Stats


Financials

RIZE FAQ

What was GeneTether Therapeutics, Inc.’s price range in the past 12 months?
GeneTether Therapeutics, Inc. lowest stock price was $0.01 and its highest was $0.18 in the past 12 months.
    What is GeneTether Therapeutics, Inc.’s market cap?
    GeneTether Therapeutics, Inc.’s market cap is $2.27M.
      When is GeneTether Therapeutics, Inc.’s upcoming earnings report date?
      GeneTether Therapeutics, Inc.’s upcoming earnings report date is May 22, 2025 which is 58 days ago.
        How were GeneTether Therapeutics, Inc.’s earnings last quarter?
        Currently, no data Available
        Is GeneTether Therapeutics, Inc. overvalued?
        According to Wall Street analysts GeneTether Therapeutics, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does GeneTether Therapeutics, Inc. pay dividends?
          GeneTether Therapeutics, Inc. does not currently pay dividends.
          What is GeneTether Therapeutics, Inc.’s EPS estimate?
          GeneTether Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does GeneTether Therapeutics, Inc. have?
          GeneTether Therapeutics, Inc. has 75,744,675 shares outstanding.
            What happened to GeneTether Therapeutics, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of GeneTether Therapeutics, Inc.?
            Currently, no hedge funds are holding shares in TSE:RIZE

            Company Description

            GeneTether Therapeutics, Inc.

            GeneTether Therapeutics, Inc. (RIZE) is a biotechnology company focused on developing innovative gene editing technologies to treat genetic disorders. The company operates in the biotech and healthcare sectors, primarily working on pioneering approaches to enhance the precision and efficiency of gene editing. GeneTether Therapeutics aims to address unmet medical needs by creating therapies that can correct genetic mutations at their source.
            Similar Stocks
            Company
            Price & Change
            Follow
            OrganiGram Holdings
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis